ProPhase Labs, Inc. (PRPH): Shareholders' Equity
$3.51M
As of 2025-12-31
-$3.11M
As of 2026-06-30
-61.9%
3-year compound annual growth
-19.8%
5-year compound annual growth
-8.8%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.51M | -52.3% | 2026-06-01, Balance as of period end |
| 2024-12-31 | $7.35M | -85.1% | 2026-06-01, Balance as of period end |
| 2023-12-31 | $49.38M | -22.4% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $63.63M | +8.5% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $58.63M | +455.4% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $10.56M | -6.0% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $11.23M | -31.9% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $16.50M | -48.2% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $31.85M | +434.2% | 2019-03-26, Balance as of period end |
| 2016-12-31 | $5.96M | -32.5% | 2018-08-20, Balance as of period end |
| 2015-12-31 | $8.83M | -17.6% | 2018-08-20, Balance as of period end |
| 2014-12-31 | $10.72M | -14.9% | 2017-02-24, Balance as of period end |
| 2013-12-31 | $12.60M | +10.0% | 2016-03-29, Balance as of period end |
| 2012-12-31 | $11.45M | +2.0% | 2015-03-27, Balance as of period end |
| 2011-12-31 | $11.23M | -16.6% | 2014-03-27, Balance as of period end |
| 2010-12-31 | $13.46M | -4.3% | 2013-03-28, Balance as of period end |
| 2009-12-31 | $14.06M | n/a | 2012-03-07, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $3.51M | -52.3% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $22.74M | +193.5% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $18.22M | -53.5% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $3.21M | -13.3% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.80M | -9.5% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $47.70M | -24.5% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $26.88M | -1.8% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $7.40M | +23.1% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $51.44M | -67.9% |
Compare PRPH, CPHI, CRVO, ENSC side by side · Screen every company in Pharmaceutical Preparations ↗